Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-424
Closed -$1.68K 820
2022
Q1
$1.68K Hold
424
﹤0.01% 769
2021
Q4
$1.73K Buy
+424
New +$1.73K ﹤0.01% 670
2020
Q4
Sell
-6,176
Closed -$20.3K 835
2020
Q3
$20.3K Sell
6,176
-81,639
-93% -$313K 0.01% 441
2020
Q2
$349K Sell
87,815
-120,655
-58% -$465K 0.09% 180
2020
Q1
$605K Buy
208,470
+137,522
+194% +$866K 0.17% 108
2019
Q4
$614K Buy
70,948
+46,883
+195% +$404K 0.11% 147
2019
Q3
$220K Sell
24,065
-35,264
-59% -$321K 0.04% 239
2019
Q2
$451K Sell
59,329
-101,510
-63% -$735K 0.08% 179
2019
Q1
$936K Buy
+160,839
New +$966K 0.19% 122

Other funds holding BRFS

Exane Derivatives's BRFS Position: Q2 2022 in Review

Exane Derivatives sold out of BRF SA (BRFS) in Q2 2022, closing a stake of 424 shares — an estimated $1.68K sold.

Exane Derivatives first reported a position in BRFS in Q1 2019 and held it in 9 quarters. The position peaked at $936K in Q1 2019. 90 funds tracked by Wall St. Rank hold BRFS as of Q2 2022.

  • Exane Derivatives reported no remaining BRF SA position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 424 BRF SA shares in Q2 2022, an estimated $1.68K.
  • Exane Derivatives first reported a position in BRF SA in Q1 2019 and held it in 9 quarters.
  • Exane Derivatives's BRF SA position peaked at $936K in Q1 2019.
  • 90 funds tracked by Wall St. Rank held BRF SA as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.